Advertisement

The Scientist

» drug development, ecology and disease/medicine

Most Recent

image: Mixed Report for Oiled Salt Marshes

Mixed Report for Oiled Salt Marshes

By | June 25, 2012

Louisiana’s salt marshes are recovering from the Deepwater Horizon oil spill, but some areas have been irreversibly lost.

3 Comments

image: Opinion: Text Mining Medicine

Opinion: Text Mining Medicine

By | June 25, 2012

Researchers should scour historic medical archives to discover knowledge that could inform today’s biomedical research and clinical practice.

9 Comments

image: The Gigapixel Camera

The Gigapixel Camera

By | June 22, 2012

A single camera unit can capture a moment in time at a mind-boggling resolution.

1 Comment

image: Five Mutations Make H5N1 Airborne

Five Mutations Make H5N1 Airborne

By | June 21, 2012

The second of the two controversial bird flu papers is published in Science, revealing that just five mutations can render the virus transmissible between ferrets.

3 Comments

image: Roundup from Microbiology Meeting

Roundup from Microbiology Meeting

By | June 21, 2012

Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.

0 Comments

image: “Extinct” Toad Rediscovered

“Extinct” Toad Rediscovered

By | June 21, 2012

A yellow-bellied dwarf toad, last sighted in 1876, is rediscovered in Sri Lanka.

0 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: New FDA Review Process Debated

New FDA Review Process Debated

By | June 20, 2012

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

0 Comments

image: Cannabis Catch-All?

Cannabis Catch-All?

By | June 20, 2012

Researchers in the U.K. are looking to breed marijuana to make medicines for metabolic disorders, epilepsy, and other diseases.

10 Comments

image: Opinion: On the Up and Up

Opinion: On the Up and Up

By | June 20, 2012

An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.

5 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Advertisement
Life Technologies